Aileron Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Dec 23 | BuyUS$758 | James Windsor | Individual | 225 | US$3.37 | |
20 Nov 23 | BuyUS$9,987 | James Windsor | Individual | 5,076 | US$1.97 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 2,226 | 0.0131% |
Individual Insiders | 157,985 | 0.931% |
Institutions | 2,975,019 | 17.5% |
General Public | 13,837,282 | 81.5% |
Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 273.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
1,810,457 | US$8.6m | 0% | 100.0% | |||
717,666 | US$3.4m | -13.6% | 5.53% | |||
191,375 | US$909.0k | 0% | no data | |||
112,800 | US$535.8k | -0.01% | no data | |||
57,288 | US$272.1k | 1.37% | no data | |||
40,314 | US$191.5k | 0.95% | no data | |||
37,947 | US$180.2k | 0% | 0.05% | |||
28,297 | US$134.4k | -2.41% | no data | |||
28,019 | US$133.1k | 47.8% | no data | |||
22,341 | US$106.1k | 0% | 0.1% | |||
22,273 | US$105.8k | 0% | no data | |||
16,580 | US$78.8k | 0% | 0.01% | |||
15,773 | US$74.9k | 0% | 0.01% | |||
7,347 | US$34.9k | 37.4% | no data | |||
3,750 | US$17.8k | 0% | no data | |||
3,745 | US$17.8k | 0% | no data | |||
3,715 | US$17.6k | 0% | no data | |||
3,638 | US$17.3k | 0% | no data | |||
2,226 | US$10.6k | -50.6% | no data | |||
2,170 | US$10.3k | 0% | no data | |||
2,144 | US$10.2k | 0% | no data | |||
1,590 | US$7.6k | 0% | no data | |||
1,250 | US$5.9k | 0% | no data | |||
1,250 | US$5.9k | 0% | no data | |||
377 | US$1.8k | 0% | no data |